Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05907954
Title (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IDEAYA Biosciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | DEU | CAN | AUS


No variant requirements are available.